TW200734335A - Compounds - Google Patents

Compounds

Info

Publication number
TW200734335A
TW200734335A TW095128913A TW95128913A TW200734335A TW 200734335 A TW200734335 A TW 200734335A TW 095128913 A TW095128913 A TW 095128913A TW 95128913 A TW95128913 A TW 95128913A TW 200734335 A TW200734335 A TW 200734335A
Authority
TW
Taiwan
Prior art keywords
compounds
diseases
indirectly
decrease
activity
Prior art date
Application number
TW095128913A
Other languages
English (en)
Inventor
Andrew John Eatherton
Gerard Martin Paul Giblin
William Leonard Mitchell
Alan Naylor
Lee William Page
Martin Swarbrick
Jennifer Anne Sweeting
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0516380A external-priority patent/GB0516380D0/en
Priority claimed from GB0524324A external-priority patent/GB0524324D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of TW200734335A publication Critical patent/TW200734335A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW095128913A 2005-08-09 2006-08-07 Compounds TW200734335A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0516380A GB0516380D0 (en) 2005-08-09 2005-08-09 Compounds
GB0524324A GB0524324D0 (en) 2005-11-29 2005-11-29 Compounds

Publications (1)

Publication Number Publication Date
TW200734335A true TW200734335A (en) 2007-09-16

Family

ID=37192394

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095128913A TW200734335A (en) 2005-08-09 2006-08-07 Compounds

Country Status (17)

Country Link
US (1) US20080221097A1 (zh)
EP (1) EP1912985A1 (zh)
JP (1) JP2009504587A (zh)
KR (1) KR20080034457A (zh)
AR (1) AR055601A1 (zh)
AU (1) AU2006278191A1 (zh)
BR (1) BRPI0614272A2 (zh)
CA (1) CA2618165A1 (zh)
CR (1) CR9787A (zh)
EA (1) EA200800562A1 (zh)
IL (1) IL188924A0 (zh)
MA (1) MA29694B1 (zh)
MX (1) MX2008001935A (zh)
NO (1) NO20081195L (zh)
PE (1) PE20070239A1 (zh)
TW (1) TW200734335A (zh)
WO (1) WO2007017237A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0705803D0 (en) * 2007-03-28 2007-05-02 Glaxo Group Ltd Novel compounds
US8524727B2 (en) 2009-03-30 2013-09-03 Astellas Pharma Inc. Pyrimidine compound
RU2012138162A (ru) 2010-02-08 2014-03-20 Аллерган, Инк. Производные пиридазина для использования в качестве агонистов каннабинода-2
EA024353B1 (ru) * 2010-07-29 2016-09-30 Астеллас Фарма Инк. Конденсированные циклические соединения пиридина

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379404D1 (en) * 1982-12-29 1989-04-20 Kureha Chemical Ind Co Ltd Cephalosporin derivatives
US5112820A (en) * 1990-03-05 1992-05-12 Sterling Drug Inc. Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US6696448B2 (en) * 1996-06-05 2004-02-24 Sugen, Inc. 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
ATE237023T1 (de) * 1998-01-23 2003-04-15 Voith Paper Patent Gmbh Verfahren zur entfernung von feinen verunreinigungen aus einer faserstoffsuspension
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
US7332494B2 (en) * 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
WO2002020002A2 (en) * 2000-09-06 2002-03-14 Ortho Mcneil Pharmaceutical, Inc. A method for treating allergies
US20040063744A1 (en) * 2002-05-28 2004-04-01 Tao Wang Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
JP2005539036A (ja) * 2002-08-21 2005-12-22 グラクソ　グループ　リミテッド ピリミジン化合物
GB0222493D0 (en) * 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
BRPI0407493A (pt) * 2003-02-14 2006-02-14 Wyeth Corp derivados heterociclil-3-sulfinilazaindol ou -azaindazol como ligantes de 5-hidroxitriptamina-6
US20040214856A1 (en) * 2003-04-23 2004-10-28 Pfizer Inc Cannabinoid receptor ligands and uses thereof
PE20060430A1 (es) * 2004-06-09 2006-05-25 Glaxo Group Ltd Derivados de pirrolopiridina como moduladores de los receptores cannabinoides

Also Published As

Publication number Publication date
EA200800562A1 (ru) 2008-06-30
PE20070239A1 (es) 2007-04-01
AU2006278191A1 (en) 2007-02-15
IL188924A0 (en) 2008-08-07
US20080221097A1 (en) 2008-09-11
WO2007017237A1 (en) 2007-02-15
KR20080034457A (ko) 2008-04-21
CA2618165A1 (en) 2007-02-15
MX2008001935A (es) 2008-03-26
BRPI0614272A2 (pt) 2011-03-22
EP1912985A1 (en) 2008-04-23
JP2009504587A (ja) 2009-02-05
NO20081195L (no) 2008-04-28
MA29694B1 (fr) 2008-08-01
AR055601A1 (es) 2007-08-29
CR9787A (es) 2008-05-05

Similar Documents

Publication Publication Date Title
TW200611695A (en) Pyrrolopyridine derivatives
GB0222495D0 (en) Compounds
UA83194C2 (ru) Производные пиримидина и их применение как модуляторов св2
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200638934A (en) Heteroaryl compounds as P2Y1 receptor inhibitors
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
ATE520668T1 (de) Sigmarezeptor-inhibitoren
GB0625648D0 (en) Compounds
MX2010003117A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200745122A (en) New compounds I
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MY150098A (en) Benzylpiperazine derivates and their medical use
GB0524814D0 (en) Compounds
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
AU2003260436A1 (en) Pyrimidine compounds
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
TW200745133A (en) New compounds II